Skip to content
FIND A HEALTH VALLEY ACTOR

Debiopharm invests CHF 30 million in a life sciences building in Valais

Debiopharm Valais

This new facility will host some 2400 m2 of research laboratories, in Martigny where Debiopharm’s workforce jumped from 150 to 200 collaborators in twelve months.       Debiopharm Research & Manufacturing (Debiopharm) is pleased to announce, on 25 October 2023, the launch and first groundbreaking of the construction work for its Innovation building in…

Read More

HUG Innovation Day: A Pioneer Of New Therapies For Deafness Awarded

HUG Innovation DAY 2023

On the occasion of their 17th Innovation Day, held on 19 October, the Geneva University Hospitals (HUG), in partnership with the Faculty of Medicine of the University of Geneva (UNIGE), awarded the 2023 Innovation Prize to the project “The Phoenix platform – a catalyst for the development of new therapies for deafness” and two trophies…

Read More

Lagosta partners with Merck for the distribution of Chitosan

Lagosta

LAGOSTA S.A. announces that it has entered into a collaboration with the global science and technology company Merck for the distribution of LAGOSTA’s unique chitosan.     Chitosan compound can be used by pharma, biotech and the biomedical industry for R&D use only, in drug delivery applications, 3D bioprinting and medical devices. Under the agreement,…

Read More

Lonza: 300 jobs in Visp for a new vaccine

Ibex™ Lonza facilit in Visp Switzerland

Lonza’s Visp site is preparing to manufacture components of a vaccine to protect against pneumococcus. Hundreds of jobs are at stake.     For Lonza, each day is different. After losing the contract to produce the active ingredients of the anti-Covid vaccine designed by Moderna, the company has just extended its collaboration with Californian company…

Read More

Emovo Care receives a CHF 100’000 FIT loan

Emovo Care

The FIT (Fondation pour l’Innovation Technologique) in Canton of Vaud supports Emovo Care with a FIT Tech Seed loans of CHF 100’000     Emovo Care isL spin-off. The start-up is at the forefront of medical technology with its innovative hand exoskeleton tailored for patients suffering from neurological or orthopaedic injuries. This groundbreaking device will…

Read More

Limula wins the $250,000 BioTools Innovator Grand Prize

Limula BioTools Innovators

BioTools Innovator, a Los Angeles-based accelerator focused on life science tools companies, awarded Limula the grand prize of the BioTools Innovator 2023 Final competition. The swiss medtech company receives a $250,000 non-dilutive prize and the title of 2023 BioTools Innovator.     Limula, an EPFL spin-off, offers an automated tool for scalable cell therapy manufacturing.…

Read More

CNS Therapy secures a CHF 1.1 Million investment

CNS Therapy

The Jura-based start-up, CNS Therapy, has raised a seed round funding totalling CHF 1 Million from private investors and CHF 139,200 in Jura Cantonal funding.     CNS Therapy is developing a drug-free pain relief management solution that combines the use of a patented medical device with interactive therapy. While many traditional treatments for chronic…

Read More

SmartCardia received FDA clearance for its ECG monitoring patch and cloud platform

Smartcardia

The EPFL-spin-off created the SmartCardia’s 7L patch, an easy-to-wear, cable-free, waterproof device that can be used for continuous monitoring for up to 14 days.     SmartCardia’s 7L patch and cloud platform is a single solution that covers the entire spectrum of cardiac monitoring including screening, post-operative follow-up, and remote patient monitoring. It has been…

Read More

4 new Medtech Start-Ups join the DayOne Tech Accelerator in Canton of Jura

DayOne Tech

The DayOne Tech accelerator for medtech project is a pillar of the Jura’s medical technology economy. Four new start-ups joined the programme and the six companies already involved in Courroux. They begin a 12-month acceleration programme with expert support. The aim is to propel them into the ranks of successful companies.       Xana…

Read More

Innovations at the CHUV in the treatment of lymphoedema

Chuv Lymphoedema

Swelling of one or more limbs as a result of lymphoedema – a common but little-understood condition – affects one in five women undergoing breast cancer surgery following the operation. The CHUV is offering two promising new methods for treating this condition.     The lymphatic network comprises vessels, lymph nodes and organs that circulate…

Read More